Abstract
Children and adolescents with ASD are frequently referred for treatment of maladaptive behaviors, including aggression, self-injury, mood dysregulation, and irritability. Concern about the potential for harm to themselves and others in addition to the failure of behavioral interventions creates a need for evidence-based pharmacotherapy. Participants will review: 1) evidence-based pharmacological interventions that reduce the frequency and intensity of acute agitation, self-injurious behaviors, irritability, and impulsive aggression in youth with ASD; 2) safety strategies for outpatient visits; and 3) treatment options for patients with ASD and co-occurring conditions such as ADHD and bipolar disorder, which may be challenging due to side effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
